GH Research PLC Blog | Talkmarkets | Page 1
No data available
No data available

Latest Posts

About This Stock More About This Stock
E Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021!
Article By: Lorimer Wilson
Sunday, January 2, 2022 2:40 AM EST
Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the answers.
In this article: ATAI, CMPS, MYCOF, ENVB, GHRS
Read
E Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline
Article By: Lorimer Wilson
Sunday, December 12, 2021 11:46 AM EST
The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same timeframe.
In this article: LKYSF, ATAI, CMPS, MYCOF, TRUFF, ENVB, GHRS, ALID
Read
E Psychedelic Stocks Rebounded 9% Last Week; Small Pharma Was Up 148%
Article By: Lorimer Wilson
Sunday, October 24, 2021 8:00 PM EST
The Psychedelic Compounds-Based Drug Stocks Index was up +8.9% last week albeit still down -18.5% YTD.
In this article: ATAI, CMPS, MYCOF, TRUFF, GHRS, DMTTF, AWKNF
Read
Software Startup Sprinklr Falls In Market Debut, More IPO News
Article By: The Fly
Sunday, June 27, 2021 5:23 PM EST
Shares of Sprinklr fell almost 9% in their market debut Wednesday, valuing the startup at $3.7B. Doximity sold well above range and ended the week even higher. Didi and Krispy Kreme are among in-focus, upcoming IPOs
In this article: SVFD, CXM, ELEV, DOCS, DLO, CFLT, MF, TKNO, MCW, DIDI, GRPH, GHRS, ACXP, GLUE, BHG, GRVI, MIRO, BON, FA, YMM, DNUT, RGCB
Read

Latest Tweets for $GHRS

No tweets yet!

PARTNER HEADLINES